Govt. caps trade margins on 137 anti-cancer drugs
The revised prices will become effective from November 9
The National Pharmaceutical Pricing Authority (NPPA) has implemented a trade margin rationalization (TMR) on 137 non-scheduled anti-cancer drugs. This move aims to make cancer treatment more affordable and improve access to these essential medicines. The revised prices will take effect from November 9.
Written by urgent.news from The Hindu - Sci-Tech's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
Also reported by 1 other outlet
- Govt. caps trade margins on 137 anti-cancer drugs thehindu.com
